Is CAR T a Drug or a Therapeutic Pathway? Intention to Treat Versus Per Protocol Analysis of Real World Studies of CAR-T Cell Therapy in Relapsed Refractory Diffuse Large B Cell Lymphoma Rossana Di Staso , Beatrice Casadei , Frederick L Locke , Michael Jain , Timothy J Voorhees , Adam S Kittai , Mariana Bastos-Oreiro , Antonio Gutiérrez , Alejandro Martin Garcia-Sancho , Maria Jose Terol , Monica Mead , Michael J Maranzano , Gloria Iacoboni , Pere Barba , Mi Kwon , Rebeca Bailen , Juan Luis Reguera-Ortega , Agrima Mian , Brian Hill , Emmanuel Bachy , Franck Morschhauser , Roch Houot , Catherine Thieblemont , Steven Le Gouill , Riccardo Masetti , Davide Gori , Alessandro Broccoli , Pier Luigi Zinzani , Lisa Argnani Blood cancer journal（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
